چكيده فارسي :
In the realm of biomedical engineering, addressing health disparities presents a paramount challenge. These disparities often manifest as unequal access to cutting-edge medical research tools and hindered progress in understanding and treating diseases. The existing drug development procedures, characterized by their high costs and protracted timelines, significantly impede access to affordable therapeutics, exacerbating disparities in healthcare accessibility. Tissue engineering, including bioprinting and organs on chip, has the potential to enhance healthcare accessibility. It accelerates drug development, customizes implants, and promotes regenerative medicine, reducing costs and improving treatment outcomes, ultimately benefitting patients by providing more affordable and effective healthcare solutions. In this lecture, I will delve into recent breakthroughs from my group, which leverage microfluidic ad bioprinting technologies to craft tissue-mimicking models tailored for drug screening and disease modeling, aligning with our overarching goal of advancing health equity through innovative biomedical engineering.
